NASDAQ:IRTC - Irhythm Technologies Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $83.19 -1.53 (-1.81 %) (As of 07/20/2018 04:00 PM ET)Previous Close$83.19Today's Range$83.16 - $85.5152-Week Range$40.12 - $89.73Volume152,567 shsAverage Volume332,454 shsMarket Capitalization$2.00 billionP/E Ratio-63.99Dividend YieldN/ABeta1.44 Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California. Receive IRTC News and Ratings via Email Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical SymbolNASDAQ:IRTC CUSIPN/A Webwww.irhythmtech.com Phone415-632-5700 Debt Debt-to-Equity Ratio0.45 Current Ratio6.59 Quick Ratio6.48 Price-To-Earnings Trailing P/E Ratio-63.99 Forward P/E Ratio-52.99 P/E GrowthN/A Sales & Book Value Annual Sales$98.51 million Price / Sales19.93 Cash FlowN/A Price / CashN/A Book Value$3.46 per share Price / Book24.04 Profitability EPS (Most Recent Fiscal Year)($1.30) Net Income$-29,420,000.00 Net Margins-32.73% Return on Equity-43.37% Return on Assets-26.92% Miscellaneous Employees575 Outstanding Shares23,600,000Market Cap$1,999.40 Irhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions What is Irhythm Technologies' stock symbol? Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC." How were Irhythm Technologies' earnings last quarter? Irhythm Technologies Inc (NASDAQ:IRTC) posted its quarterly earnings data on Wednesday, May, 2nd. The company reported ($0.47) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.36) by $0.11. The business had revenue of $30.60 million for the quarter, compared to the consensus estimate of $29.07 million. Irhythm Technologies had a negative net margin of 32.73% and a negative return on equity of 43.37%. The business's revenue for the quarter was up 43.0% on a year-over-year basis. During the same quarter last year, the business posted ($0.24) EPS. View Irhythm Technologies' Earnings History. When is Irhythm Technologies' next earnings date? Irhythm Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for Irhythm Technologies. What price target have analysts set for IRTC? 7 brokers have issued twelve-month price objectives for Irhythm Technologies' shares. Their predictions range from $60.00 to $93.00. On average, they anticipate Irhythm Technologies' share price to reach $79.50 in the next twelve months. This suggests that the stock has a possible downside of 4.4%. View Analyst Ratings for Irhythm Technologies. What is the consensus analysts' recommendation for Irhythm Technologies? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Irhythm Technologies in the last year. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." What are Wall Street analysts saying about Irhythm Technologies stock? Here are some recent quotes from research analysts about Irhythm Technologies stock: 1. According to Zacks Investment Research, "iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. " (7/4/2018) 2. Northland Securities analysts commented, "We note that this was a physician-initiated study and funded by Bardy. Also, it is important to take this study within the context of an initial study which could provide clues for a larger head-head study, providing important clues for the sensitivity & specificity of R-R wave vs. P-wave analysis in ambulatory ECG monitoring." (4/16/2018) 3. Canaccord Genuity analysts commented, "We expect these data, assuming the read-out of the full study data follows suit (which we expect), will build IRTC’s case with payers, paving the way ultimately for prospective screening with Zio in a brand new, 3- million-patient TAM. While not in our model at all, we think over time, payors will cover Zio for screening of high-risk patients defined by the mSToPs study. We reiterate our BUY rating and $59 price target." (11/14/2017) Who are some of Irhythm Technologies' key competitors? Some companies that are related to Irhythm Technologies include Hill-Rom (HRC), ICU Medical (ICUI), Insulet (PODD), Haemonetics (HAE), Globus Medical (GMED), Penumbra (PEN), Cantel Medical (CMD), Novocure (NVCR), Merit Medical Systems (MMSI), NuVasive (NUVA), Nevro (NVRO), Mazor Robotics (MZOR), Luminex (LMNX), Glaukos (GKOS) and Tandem Diabetes Care (TNDM). Who are Irhythm Technologies' key executives? Irhythm Technologies' management team includes the folowing people: Mr. Kevin M. King, Pres, CEO & Director (Age 62)Mr. Matthew C. Garrett, Chief Financial Officer (Age 50)Mr. David A. Vort, Exec. VP of Sales (Age 52)Dr. Derrick Sung, Exec. VP of Strategy & Corp. Devel. (Age 45)Ms. Judith C. Lenane RN, MHA, Chief Clinical Officer and Exec. VP of Operations (Age 59) When did Irhythm Technologies IPO? (IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Has Irhythm Technologies been receiving favorable news coverage? News headlines about IRTC stock have trended somewhat negative this week, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Irhythm Technologies earned a daily sentiment score of -0.02 on Accern's scale. They also gave headlines about the company an impact score of 47.17 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term. Who are Irhythm Technologies' major shareholders? Irhythm Technologies' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Xact Kapitalforvaltning AB (0.02%) and Amalgamated Bank (0.02%). Company insiders that own Irhythm Technologies stock include David A Vort, Derrick Sung, Kevin M King, Matthew C Garrett, Raymond W Scott, Synergy Life Science Partners and Vijay K Lathi. View Institutional Ownership Trends for Irhythm Technologies. Which major investors are buying Irhythm Technologies stock? IRTC stock was purchased by a variety of institutional investors in the last quarter, including Xact Kapitalforvaltning AB and Amalgamated Bank. View Insider Buying and Selling for Irhythm Technologies. How do I buy shares of Irhythm Technologies? Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Irhythm Technologies' stock price today? One share of IRTC stock can currently be purchased for approximately $83.19. How big of a company is Irhythm Technologies? Irhythm Technologies has a market capitalization of $2.00 billion and generates $98.51 million in revenue each year. The company earns $-29,420,000.00 in net income (profit) each year or ($1.30) on an earnings per share basis. Irhythm Technologies employs 575 workers across the globe. How can I contact Irhythm Technologies? Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, SAN FRANCISCO CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected] MarketBeat Community Rating for Irhythm Technologies (NASDAQ IRTC)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 125 (Vote Outperform)Underperform Votes: 116 (Vote Underperform)Total Votes: 241MarketBeat's community ratings are surveys of what our community members think about Irhythm Technologies and other stocks. Vote "Outperform" if you believe IRTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRTC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/21/2018 by MarketBeat.com StaffFeatured Article: How do investors use RSI to grade stocks?